W. Padoani, M. Marini, L. Pavan - Vol. 8, September 2002, Issue 3
Testo Immagini Bibliografia Summary Indice
2 Shneidman E. Definition of Suicide. New York: Wiley & Sons 1985.
3 World health Organization. Changing Patterns of Suicidal Behaviour. Technical Report n° 74. Copenhagen: WHO/EURO 1982.
4 Kerkhof AJFM, Schmidtke A, Bille-Brahe U, et al. Attempted Suicide in Europe. Leiden: DSWO Press 1994.
5 De Leo D. Suicidal behaviours at the dawn of the new millennium: on their nature, magnitude, and causality. Professional Lecture. Griffith University Public Lecture Series, Mt Gravatt Campus, Brisbane, Australia 2000.
6 De Leo D, Bertolote JM, Schmidtke A, et al. Definitions in suicidology: the evidence-based and the public health approach. Presented at the 20th congress of the International Association for Suicide Prevention. Athens, 6-10 November 1999.
7 Murray CJL, Lopez AD. Global burden of disease and injury series. Vol. 1. Boston: Harvard University Press 1996.
8 World health organization. Figures and Facts about Suicide. WHO/MNH/MBD/99.1, Geneva, WHO 1999.
9 World Health Organization. The World Health Report 2001-Mental Health: New Understanding, New Hope. Geneva: WHO 2001.
10 ISTAT: Annuario Statistico Italiano. Roma, 1998.
11 Scocco P, Padoani W, Dello Buono M, et al. WHO/EURO Multicentre Study on Parasuicide: Findings from the Padua operating centre for the five-year period 1989-1993. G It Suicidol 1997;7:23-31.
12 Barraclough B, Bunch J, Nelson B. A hundred cases of suicide: clinical aspects. Br J Psychiatry 1974;125:355-73.
13 Montgomery SA, Montgomery DB. Pharmacological prevention of Suicidal Behavior. J Aff Disord 1982;4:291-8.
14 Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry 1970;117:437-8.
15 Schifano F, De Leo D. Pharmacological Treatment of Suicidal Behavior. In: De Leo D, Diekstra RFW, eds. Suicide Prevention. A Holistic Approach. Kluwer Academic Publishers, Dordrecht, The Netherlands 1998.
16 De Leo D. Fattori di Rischio nel Comportamento Suicidario. In: De Leo D, ed. Aspetti Clinici del Comportamento Suicidario. Padova: Liviana 1990.
17 World Health Organization: Preventing suicide. A resource for General Physicians. WHO/MNH/MBD/00.1, Geneva: Department of Mental Health, WHO, Mental Behav Dis 2000.
18 Isometsa ET, Henriksson MM, Heikkinen ME, Aro HM, Martunnen MJ, Kuoppasalmi KI, et al. Suicide among subjects with personality disorders. Am J Psychiatry 1996;153:667-73.
19 Mercy JA, Kresnow MJ, O’Carroll PW, Lee RK, Powell KE, Potter LB, et al. Is suicide contagious? A study of the relation between exposure to the suicidal behavior of others and nearly lethal suicide attempts. Am J Epidemiol 2001;154:120-7.
20 World Health Organization: Multisite Intervention Study on Suicidal Behaviours-SUPRE-MISS. Management of Mental and Brain Disorders. Department of Mental Health and Substance Dependence. Geneva: WHO 2000.
21 Rutz W, Knorring L, Walinder J. Long-term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiat Scand 1995;85:83-8.
22 Ojehagen A, Regnell G, Traskman-Bendz L. Deliberate self-poisoning: repeaters and non-repeaters admitted to an intensive care unit. Acta Psychiat Scand 1991;84:266-71.
23 Mishara BL, Ystgaard M. Exploring the potential for primary prevention: evaluation of the Befrienderrs International Reaching Young People Pilot Programme in Denmark. Crisis 2000;21:4-7.
24 Bouglass D, Horton J. The repetition of parasuicide: a comparison of three cohorts. Br J Psychiatry 1974;124:168-74.
25 Hawton K, Fagg J. Suicide, and other causes of death, following attempted suicide. Br J Psychiatry 1988;152:359-66.
26 Nordentoft M, Breum L, Munc LK, et al. High mortality by natural and unnatural causes: a ten year follow-up study of patients admitted to a poisoning treatment centre after suicide attempts. BMJ 1993;306:1637-40.
27 Fawcett J. Treating impulsivity and anxiety in the suicidal patient. Ann NY Acad Sci 2001;932:94-102.
28 Meneghel G, Scocco P, Dente A, et al. Qualità della cura e costi del trattamento dei pazienti parasuicidari. G It Suicidol 1996;6:31-7.
29 Runeson B, Scocco P, De Leo D, Meneghel G, Wasserman D. Management of suicide attempts in Italy and Sweden. A comparison of services offered to consecutive samples of suicide attempters. Gen Hosp Psychiatry 2000;22:432-6.
30 World Health Organization: Preventing suicide. How to start a survivors’ group. WHO/MNH/MBD/00.6, Mental and Behavioural Disorders, Department of Mental Health, Geneva: WHO 2000.
31 World Health Organization: Preventing suicide. A resource for primary health care workers. WHO/MNH/MBD/00.4. Mental and Behavioural Disorders, Department of Mental Health, Geneva: WHO 2000.
32 Pavan L. Suicidio, le parole non dette. Verona: Positive Press 2000.
33 Beck AT, Weissman A, Lester D. The measurement of pessimism. The hopelessness scale. J Consult Clin Psychol 1974;42:861-5.
34 Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the scale for suicide ideation. J Consult Clin Psychol 1979;47:343-52.
35 Stanley B, Traskman-Bendz L, Stanley M. The Suicide Assessment Scale: a scale evaluating change in suicidal behaviour. Psychopharmacol Bull 1986;22:200-5.
36 Linehan MM, Goodstein JL, Nielsen SL, Chiles JA. Reasons for staying alive when you are thinking of killing yourself: the reasons for living inventory. J Consult Clin Psychol 1983;51:276-86.
37 Diekstra RFW, Kerkhof AJFM. Attitudes towards suicide. The development of a Suicide Attitude Questionnaire (SUIATT). In: Diekstra RFW, Maris R, Platt S et al. eds. Suicide and its Prevention. The Role of Attitude and Imitation. EJ Brill 1989.
38 Kroll J. Use of no-suicide contracts by psychiatrists in Minnesota. Am J Psychiatry 2000;157:1684-6.
39 Asberg M, Traskman M, Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predctor? Arch Gen Psychiat 1976;33:1193-7.
40 De Leo D, Marazziti D. Biological prediction of suicide: the role of serotonin. Crisis 1988;9:109-18.
41 Cohen LS, Winchel RM, Stanley M. Biological markers of suicide risk and adolescent suicide. Clin Neuropharmacol 1988;11:423-35.
42 Rao ML, Braunig P, Papassotiropoulos A. Autoaggressive behavior is closely related to serotonin avilability in schzoaffective disorders. Pharmacopsychiatry 1994;27:202-6.
43 Schifano F, De Leo D. Pharmacological Treatment of Suicidal Behavior. In: De Leo D, Diekstra RFW, eds. Suicide Prevention. A Holistic Approach. Kluwer Academic Publishers, Dordrecht, The Netherlands 1998.
44 Van Praag HM. Psychobiology of suicidal behavior. Ann NY Ac Sci 1986;487:150-67.
45 Pitchot W, Hansenne M. Ansseau: Role of dopamine in non-depressed patients with a history of suicide attempts. Eur Psychiatry 2001;16:424-7.
46 De Wilde J, Mertens C, Fredricson Overo KF, Petersen HE. Citalopram versus mianserin. Acta Psychiat Scand 1985;72:89-96.
47 Gonella G, Baignoli G, Ecari V. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study. Curr Med Res Opin 1990;12:177-84.
48 Montgomery SA, McAuley R, Rani SJ, Roy D, Montgomery DB. A double-blind comparison of zimelidine and amytriptyline in endogenous depression. Acta Psychiat Scand 1981;290(Suppl.):314-27.
49 Mujgen M, Roy D, Silverstone T et al. A comparative clinical trial of fluyoxetine, mianserin and placebo in depressed outpatients. Acta psychiat Scand 1988;78:384-90.
50 Sacchetti E, Vita A, Guarneri L, et al. The effectiveness of fluoxetine, clomipramine, nortryptiline and desipramine in major depressives with suicidal behaviour: preliminary findings. In: Cassano & Akiskal, eds. Serotonin-related psychiatric syndromes: clinical and therapeutic links, N° 165. London: Royal Society of Medicine Services Limited 1991.
51 Lopez-Ibor JJ. Reduced suicidality with paroxetine. Eur Psychiat 1993;8(Suppl.1):17-9.
52 Ottevanger EA. Fluvoxamine superior to imipramine in suicidal depressed patients. Eur Neuropsychopharmacol 1993;3:362-3.
53 Preskorn SH, Burke M. Somatic therapy for major depressive disorder: selection of an antidepressant. J Clin Psychiat 1992;53(Suppl.):5-16.
54 Wolfersdorf M. The value of psychotropic drugs in treatment of suicidal behaviour. Psychiatrische Praxis 1992;19:100-7.
55 Meltzer HY. Treatment of suicidality in schizophrenia. Ann NY Acad Sci 2001;932:44-58.
56 Michel K, Waeber W, Valach L, Arestegui G, Spuhler T. A comparison of the drugs taken in fatal and nonfatal self-poisoning. Acta Psychiat Scand 1994;90:184-9.
57 Baldessarini RJ, Tondo L, Hennen J. Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium. Ann NY Acad Sci 2001;932:24-38.
58. Gardner DL, Cowdry RW. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder. Am J Psychiat 1986;143:159-522.
59 Ringel E. Selbstmordverhutung. Verlag Hans Huber, Bern 1969.
60 Wasserman D. A critical evaluation of psychotherapy in the treatment of depression and in suicide prevention. In: De Leo D, Diekstra RFW, eds. Suicide Prevention. A Holistic Approach. Kluwer Academic Publishers, Dordrecht, The Netherlands 1998.
61 Bellak L, Small L. Emergency Psychotherapy and Brief psychotherapy. New York: Grune & Stratton 1965.
62 Wolberg LR. Handbook of Short-Therm Psychotherapy. New York: Thieme-Stratton 1980.
63 Dauwalder JP, Ciompi L. Cost effectiveness over 10 years: a study of community based social psychiatry in the 1980s. Soc Psychiatry Psychiat Epidem 1995;30:171-84.
64 van der Sande R, van Rooijen L, Buskens E, Allart E, Hawton K, van der Graaf Y, et al. Inpatient and community intervention versus routine care after attempted suicide. A randomized controlled intervention study. Br J Psychiatry 1997;171:35-41.
65 Reisch T, Schlatter P, Tschacher W. Efficacy of crisis intervention. Crisis 1999;20:78-85.
66 Invernizzi G. Emergency psychiatry. New Trends in Experimental and Clinical Psychiatry 1994;10:7-8.
67 Pavan L, Banon D. L’Intervento Psicoterapico nelle Situazioni di Crisi. Padova: Kendall 1992.
68 Pavan L, Banon D. Trauma, Vulnerabilità, Crisi. Il Trattamento della Crisi Emozionale. Torino: Bollati Boringhieri 1996.
69 Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, et al. National Institute’s of Mental health Collaborative Research Program on Treatment of Depression. General effectiveness of Treatments. Arch Gen Psychiat 1989;46:971-82.
70 Frank E, Kupfer D, Perel JM, Cornes C, Jarrett DB, Mallinger AG, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiat 1990;47:1093-9.
71 Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiat 1991;48:1060-4.
72 Linehan MM, Heard HL, Armstrong HE. Naturalistic follow-up of a behavioral treatment for chronically parasuicide borderline patients. Arch Gen Psychiat 1993;50:971-4.